$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20210320043230_bharat-biotech-covaxin-packshot.jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 115]
$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20210320043230_bharat-biotech-covaxin-packshot.jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 116]
//find the group of logged user
$groupId = $user['Group']['id'];
$user_id=$user["id"];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20210320043230_bharat-biotech-covaxin-packshot.jpg'
$user = null
$groupId = null
include - APP/View/Articles/view.ctp, line 116
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20210320043230_bharat-biotech-covaxin-packshot.jpg'
$user = null
$groupId = null
$user_id = null
$date = '2021-03-20 16:28:40'
$dateFromDatabase = (int) 1616237020
$newDate = 'Mar 20, 2021'
$articleView = array(
'article_id' => '13186',
'hit' => '1254'
)
$word_count = (int) 204
$time_to_read = (float) 1.02
$time_to_read_min = (float) 1
$time_to_read_second = (float) 1
include - APP/View/Articles/view.ctp, line 241
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
March 20:
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.
Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.
Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use.
The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.
FormHelper::create() - CORE/Cake/View/Helper/FormHelper.php, line 383
include - APP/View/Articles/view.ctp, line 273
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 60]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
file not found!
Notice (8): Undefined variable: file [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '13186',
'article_category_id' => '1',
'title' => 'Govt approves Indian COVAXIN as third Covid vaccine for emergency use in Nepal ',
'sub_title' => '',
'summary' => 'The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN. ',
'content' => '<p>March 20:<br />
The government has granted permission for the emergency use authorization of another Indian-manufactured Covid-19 vaccine, COVAXIN.</p>
<p>Issuing a statement on Friday, the Department of Drug Administration (DDA) said that it decided to grant conditional permission for emergency use authorization of COVAXIN, a Covid-19 vaccine manufactured by Bharat Biotech International Limited, Hyderabad, India.</p>
<p>Covaxin has become third Covid vaccine in Nepal to acquire the permission from the government for the emergency use. With this, two Covid vaccines from India and one from China will be allowed to be administered in Nepal. Covid vaccine developed by Chinese Sinopharm and Covishield, a vaccine developed by Oxford/AstraZeneca and manufactured by Serum Institute of India Pvt Ltd, have already received approval from the DDA for the emergency use. </p>
<p>The government is currently administering Covishield vaccines to the people as part of its nationwide vaccination drive. While the Indian government had provided 1 million doses of Covishield to Nepal in grant, the government later decided to purchase 2 million doses from Serum Institute of India. Out of the total vaccines that the government decided to purchase, Serum Institute is yet to supply 1 million doses to Nepal.</p>
<p> </p>
',
'published' => true,
'created' => '2021-03-20',
'modified' => '2021-03-20',
'keywords' => '',
'description' => '',
'sortorder' => '12932',
'image' => '20210320043230_bharat-biotech-covaxin-packshot.jpg',
'article_date' => '2021-03-20 16:28:40',
'homepage' => true,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '35'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '35',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'sagar.ghimire@newbusinessage.com',
'name' => null,
'email' => 'sagar.ghimire@newbusinessage.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => false,
'sortorder' => null,
'published' => null,
'created' => '2021-02-08 16:36:44',
'last_login' => '2023-04-24 12:51:39',
'ip' => '141.101.68.96'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '13186',
'hit' => '1254'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
